You are here

  • Home
  • Archive
  • Volume 29, Issue 6
  • Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

Article metrics

Article menu
Download PDFPDF
Original Article
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

 

Online download statistics by month:

Online download statistics by month: July 2019 to April 2024

AbstractFullPdf
Jul 201915484839
Aug 201912694925
Sep 2019293129
Oct 2019202168
Nov 2019186133
Dec 2019182155
Jan 202014736
Feb 20202351011
Mar 202023285
Apr 202021964
May 202019079
Jun 202022887
Jul 202011022
Aug 202014402
Sep 202012521
Oct 202010623
Nov 20209022
Dec 202011563
Jan 202119342
Feb 202112601
Mar 20219511
Apr 2021170118
May 2021791111
Jun 2021372827
Jul 2021742
Aug 2021211
Sep 2021735
Oct 202113201
Nov 202117955
Dec 20216354
Jan 20227693
Feb 20229856
Mar 202212276
Apr 202212943
May 2022226129
Jun 2022222114
Jul 202214331
Aug 2022225113
Sep 202216183
Oct 20221611613
Nov 202221864
Dec 202215620
Jan 202322053
Feb 202320194
Mar 202321283
Apr 202318885
May 202322547
Jun 202317475
Jul 202314642
Aug 202317555
Sep 202330631
Oct 202323644
Nov 202322344
Dec 2023235813
Jan 202418892
Feb 202418854
Mar 2024236188
Apr 2024125117
Total11926488344